First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases

Cardiol J. 2020;27(5):639-641. doi: 10.5603/CJ.a2020.0100. Epub 2020 Aug 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Male
  • Poland
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Symporters*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose